Stephen J Halliday MD MSCI
Critical Care Medicine, Interstitial Lung Diseases
Associate Professor of Medicine
Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-263-7203
Dr. Halliday is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a pulmonary and critical care physician with an interest in interstitial lung disease, critical care, bronchoscopy and other pulmonary procedures, and medical education. I completed my residency, chief residency, and fellowship at Vanderbilt, and now practice at University of Wisconsin Hospitals and Clinics, and the William S. Middleton VA Hospital. My research interest is primarily in clinical trials for ILD and airway management in ICU.
Education & Training
Vanderbilt UniversityMSCI, 2017 - 2019
Vanderbilt University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2015 - 2019- Vanderbilt University Medical CenterChief Residency, Internal Medicine, 2014 - 2015
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2011 - 2014
The University of Texas Health Science Center at San AntonioClass of 2011, M.D.- Davidson CollegeBS, Biology, 2003 - 2007
Certifications & Licensure
IL State Medical License 2019 - 2026
WI State Medical License 2019 - 2025
TN State Medical License 2013 - 2021
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Distinction in Leadership Training Vanderbilt University Medical Center, 2015
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care Start of enrollment: 2018 Nov 05
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis Start of enrollment: 2021 Mar 19
- Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2020 Sep 30
- Join now to see all
Publications & Presentations
PubMed
- Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials.Stephanie C DeMasi, Wesley H Self, Neil R Aggarawal, Michael D April, Luke Andrea
Annals of Emergency Medicine. 2025-01-01 - Diabetes Mellitus Is Not a Risk Factor for Difficult Intubation Among Critically Ill Adults: A Secondary Analysis of Multicenter Trials.Micah T Long, Bryan M Krause, Audrey de Jong, John T Dollerschell, J Michael Brewer
Critical Care Medicine. 2025-01-01 - 24 citationsNoninvasive Ventilation for Preoxygenation during Emergency Intubation.Kevin W Gibbs, Matthew W Semler, Brian E Driver, Kevin P Seitz, Susan B Stempek
The New England Journal of Medicine. 2024-06-20
Press Mentions
Researchers at Vanderbilt Publish First Study from PHA’s 2018 Research RoomNovember 29th, 2018
Grant Support
- Clinical and Translational Research Training Program in Pulmonary MedicineNIH2017–2019
Professional Memberships
- Member
- Member
- Pulmonary Hypertension AssociationMember
- Member
External Links
- UW Sitehttps://www.uwhealth.org/findadoctor/profile/stephen-j-halliday-md/11168
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
